| Communicable Disease Prevention and Control (40500) | $468,799,929 | $246,001,145 |
| Immunization Program (40502) | FY2023 $42,336,171 | FY2024 $62,336,171 |
| Tuberculosis Prevention and Control (40503) | FY2023 $2,282,896 | FY2024 $2,282,896 |
| Sexually Transmitted Disease Prevention and Control (40504) | FY2023 $4,603,141 | FY2024 $4,603,141 |
| Disease Investigation and Control Services (40505) | FY2023 $327,680,833 | FY2024 $85,032,049 |
| HIV/AIDS Prevention and Treatment Services (40506) | FY2023 $89,218,326 | FY2024 $89,068,326 |
| Pharmacy Services (40507) | FY2023 $2,678,562 | FY2024 $2,678,562 |
| Fund Sources: | | |
| General | FY2023 $14,569,348 | FY2024 $14,569,348 |
| Special | FY2023 $2,744,383 | FY2024 $2,744,383 |
| Federal Trust | FY2023 $451,486,198 | FY2024 $228,687,414 |